Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting this drug and one Paragraph…
Source
New patent expiration for Shionogi Inc drug ULESFIA Read Post »
Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier. There is one patent…
Source
New patent expiration for Validus Pharms drug EQUETRO Read Post »
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs…
Source
Which pharmaceutical companies have the most suppository dosed drugs? Read Post »
Annual Drug Patent Expirations for TADLIQ Tadliq is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are six…
Source
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are four…
Source
Annual Drug Patent Expirations for TYMLOS Tymlos is a drug marketed by Radius and is included in one NDA. It is available from one supplier. There are eight patents protecting…
Source
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. It is available from one supplier. There are fifty-eight…
Source
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
Source
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are twelve…
Source
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Get new actionable insights and updates from BiotechBlog
